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Objectives. This analysis was performed toquantitatively assess 
the relative risks, associated with underlying cardiovascular dis- 
ease, incurred in the course of intense competitive sports. 
Background. Sudden cardiac death during athletic activities is 
a highly visible event, and controversy persists regarding the true 
risks associated with participation in sports. 
Methods. The prevalence ofsudden death was assessed in two 
systematically tabulated groups of endurance runners competing 
in the annual Marine Corps (1976 to 1994) and Twin Cities (1982 
to 1994) marathons, held over a cumulative 30.year period. 
Results. A total of 215,413 runners completed the races, and 
four exercise-related sudden deaths occurred, each due to unsus- 
pected structural cardiovascular disease. Three deaths occurred 
during the race (after 15 to 24 miles [24 to 38.4 kin]) and the other 
immediately after its completion. The ages were 19 to 58 years 
(average 37), and three were men. Three of the sudden deaths 
were due to atherosclerotic coronary artery disease (narrowing of 
two or three vessels) and one to anomalous origin of the left main 
coronary artery from the right sinus of Valsalva. None of the four 
runners had prior documentation f heart disease or experienced 
prodromal symptoms, and two had previously completed three 
marathon races each. The overall prevalence of sudden cardiac 
death during the marathon was only 0.002%, strikingly lower than 
for several other variables of risk for premature death calculated 
for the general U.S. population. 
Conclusions. Although highly trained athletes uch as mara- 
thon runners may harbor underlying and potentially lethal car- 
diovascular disease, the risk for sudden cardiac death associated 
with such intense physical effort was exceedingly small (1 in 
50,000) and as little as 1/100th of the annual overall risk associ- 
ated with living, either with or without heart disease. The low risk 
for sudden death identified in long-distance runners from the 
general population suggests hat routine screening for cardiovas- 
cular disease in such athletic populations may not be justifiable. 
(J Am Coll Cardiol 1996;28:428-31) 
Sudden unexpected death during sporting activities is usually 
due to underlying and often unsuspected heart disease (1-18). 
Such catastrophes often attract substantial public attention 
(19), and considerable uncertainty persists regarding the pre- 
cise risks associated with training and competition. The paucity 
of such risk assessment data has constituted a substrate for 
heightened anxiety in both the medical and lay communities 
(20,21), particularly regarding whether long-distance running 
and similar vigorous exercise may he hazardous to athletes with 
unsuspected cardiovascular disease (1,3,11-15). Indeed, dis- 
tance running has become an immensely popular sporting 
activity in the United States, involving a growing proportion of 
the general public. For this reason, we chose to study runners 
participating in the marathon to assess and place into perspec- 
tive the potential adverse cardiovascular risks associated with 
intense training and competition. 
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Methods  
Selection of subjects. The registries and case records of 
two long-standing annual marathon race programs usually held 
in October and November were reviewed, with the participants 
comprising the study population: 1) Marine Corps Marathon 
(Washington, D.C.), 1976 to 1994; and 2) Twin Cities Mara- 
thon (Minneapolis-St. Paul, Minnesota), 1982 to 1994. These 
marathon events were selected because of their accessibility to 
the general athletic community, considerable attention to 
detail in race organization and availability of reliable and 
systematically tabulated ata over substantial periods of time. 
There were no special qualifying criteria for participation i
either marathon. For those athletes who died, a retrospective 
analysis of the medical and athletic history was performed 
using available records and telephone interviews. 
Resu l ts  
Demographics of the marathon races (Table 1). From 1976 
to 1994, 215,413 runners in the Marine Corps and Twin Cities 
marathons uccessfully completed the course distance (26 
miles [41.6 kin] and 285 yd [260 m]), with the majority (155,034 
[72%]) participating in the larger and older Marine Corps 
event. The marathon runners were predominantly men (82%), 
and their average age was 37 years. 
Analysis of sudden deaths (Table 2). A total of four 
sudden deaths occurred uring or shortly after completion of 
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Table 1. Demographics of Two Marathon Populations 
Sudden Cardiac 
Race Finishers Death 
No. of % of Mean Age % With % of Race 
Marathon Years Total Average/yr Entrants* (yr) % Men Time <3 h No. Finishers 
Twin Cities 13 60,379 4,644 74.3 37.4 79.4 10.0 1 0.002 
Marine Corps 19 155,034 8,160 76.6 36.8 84.0 2.4 3 0.002 
Total: 32 215,413 6,732 75.9 37.1 82.2 - -  4 0.002 
*Although the number of race entrants (those providing a completed preraee application and the fee) was known, it was not possible to accurately ascertain the 
precise number of entrants who actually started each race. Therefore, participation i  the marathon was measured (and expressed) in terms of the most reliable data 
available (i.e., the number of runners who completed the race distance). 
the marathon race. All deaths occurred uring the most recent 
10 years of the study period, with one each in 1986, 1989, 1990 
and 1993 (Fig. 1); three deaths occurred uring the Marine Corps 
Marathon and one during the Twin Cities Marathon. The ages 
were 19 to 58 years; three were men and one was a woman. 
The prevalence of sudden cardiac death among the 215,413 
marathon race finishers was 0.002%, or 1 in 50,000. When the 
average racing time for marathon finishers is estimated to be 
-4  h, then the risk for sudden death may also be expressed as 
1 in -215,000 h of running. 
Each of the four deaths proved to be due to underlying 
structural cardiovascular disease at autopsy. Three runners, all 
men, had coronary artery disease with atherosclerotic narrow- 
ing ->50% of the cross-sectional lumen area of either two 
major extramural rteries (case 2) or three arteries (cases 3 
and 4). The fourth athlete, a 19-year old woman (case 1), had 
anomalous origin of the left main coronary artery from the 
right sinus of Valsalva (22). At autopsy, the left main coronary 
ostia appeared elliptical, and the artery followed a course 
between the aorta and pulmonary trunk until its bifurcation 
into the left anterior descending and left circumflex arteries. 
Each of the three main coronary arteries was free of athero- 
sclerosis. None of the four athletes had evidence of substantial 
myocardial fibrosis, although small focal scars or necrosis was 
evident in two. Each of the three athletes who died of coronary 
artery disease also showed an increase in heart weight (300 to 
525 g) and left ventricular wall thickness (13 to 22 ram). 
Detailed wall thickness data from all left ventricular segments 
and, hence, septal/free wall ratios were not available. An 
examination of the conduction system was not performed in 
these hearts. Results of postmortem toxicologic examinations 
of blood and urine were normal. 
Three of the four runners collapsed without apparent 
warning during the race after 15, 23 and 24 miles (24, 36.8 and 
38.4 kin) (cases 1, 2 and 4, respectively). The fourth runner, a 
40-year old man with coronary artery disease (case 3), col- 
lapsed 15 rain after the race; he had experienced chest pain 
after unning 20 miles [32 km] but completed the remainder of 
the race despite this symptom. 
Of the four runners who died, two had successfully com- 
pleted three previous marathon races, and the other two were 
competing in their first marathon. All four had trained in- 
tensively before the race, running 40 to 100 miles [64 to 
160 km]/week; none reported experiencing prodromal cardiac 
symptoms during training or prior competition, or had they 
previously documented structural heart disease. Two runners 
(cases 3 and 4) had a history of systemic hypertension for which 
medications were administered. In only one athlete was there 
a family history of sudden death (case 4). 
Comparative risk assessment. The annual probability of 
premature death was estimated for a variety of circumstances 
using the U.S. Vital Statistics for persons 15 to 54 years of age, 
and was expressed as an average annual risk taken from 3 years 
of data (1979, 1990 and 1991) (23). These values were com- 
pared with the risk calculated for running one marathon. For 
example, risk associated with the marathon proved to be less 
than that associated with general living overall (x 120), cardio- 
vascular disease (x23) or accidents (x19). 
Discuss ion 
Occurrences of sudden death on the athletic field are of 
intense interest to both the medical and lay communities (19). 
Such catastrophes in trained athletes are usually due to 
underlying and unsuspected structural cardiovascular disease 
(1-18). However, there are relatively few quantitative data 
defining the risks for sudden cardiac death associated with 
training or competition within well defined athletic popula- 
tions (3,17,20,24). Therefore, to further analyze this problem, 
we used marathon running as a model. The marathon race 
represents a vigorous and aerobic competitive sport requiring 
intensive training, characterized by a high level of public 
participation within a broad age spectrum. In addition, mara- 
thon runners can be exposed to extreme and unusual environ- 
mental conditions associated with alterations in blood volume 
and hydration that may theoretically enhance their risk for 
arrhythmias nd cardiovascular events. 
The present study analyzed two marathons that are tradi- 
tionally open to all registrants to assess the potential for 
sudden death during competitive sports within the general 
athletic population. Based on our data in >200,000 runners, 
we calculated the risk for sudden death to be very small-- 
0.002% or 1 in 50,000 race finishers. These findings suggest 
that participation i the marathon isassociated with a low risk 
for adverse consequences, despite the fact that a small (but 
undefined) proportion of the participants undoubtedly had 
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competed with unsuspected cardiovascular conditions (most 
likely coronary artery disease). Indeed, based on our calcula- 
tions, the overall risk of living for 1 year (incorporating all 
causes of mortality including cardiovascular disease) (23) was 
>100 times greater than the risk of running in a single 
marathon race. Furthermore, the mortality for all forms of 
accidents was almost 20 times greater than that associated with 
the marathon (23). However, when expressed in terms of the 
risk for sudden death or cardiac arrest per man-hours of 
competition, marathon running (1 death/215,000 h) proved to 
be somewhat less safe than certain other sporting activities, 
including general and noncompetitive forms of exercise 
(1/375,000 h) (25), jogging (1/396,000 h) (3) or cross-country 
skiing (1/607,000 h) (26). 
We should point out that because it was not possible to 
accurately determine the number of runners tarting each race, 
we used marathon finishers as the denominator for calcula- 
tions of risk. Because three of the four deaths occurred uring 
a race, and therefore the runners were regarded as nonfinish- 
ers, the prevalence of sudden death reported here may be 
slightly overestimated. 
Certain demographic and clinical features of the four 
exercise-related sudden deaths are worthy of discussion. Three 
deaths, all in male runners 32 to 58 years old, were due to 
acquired atherosclerotie coronary artery disease with either 
two- or three-vessel involvement, and little or no evidence of 
prior myocardial infarction. The other athlete (19 years old) 
had a congenital coronary malformation with anomalous origin 
of the left main coronary artery from the right sinus of Valsalva 
(22). These findings are consistent with previous observations 
in trained athletes who died of cardiovascular disease. A 
variety of congenital cardiac diseases account for athletic field 
catastrophes in younger athletes (2,4-10,17-19), whereas ath- 
erosclerotic oronary artery disease predominates in older 
athletes (1,3,11-16,24,27). In contrast, he low prevalence of 
sudden death that we identified with marathon running is 
consistent with the previous observation that sustained levels 
of vigorous physical exercise may reduce the risk for cata- 
strophic events (20,28). Indeed, that two of the three runners 
who died of coronary artery disease had each previously 
completed three marathon races demonstrates that some 
athletes with cardiovascular disease are capable of tolerating 
intensive training and competition over long periods of time 
without experiencing symptoms or collapse (29,30). 
Study limitations. Certain limitations are relevant to uti- 
lizing the marathon as a model for calculating the risk of 
sudden death associated with athletic ompetition. For exam- 
ple, marathon runners are subject to a certain degree of 
self-selection because of the intense training required in their 
sport. Hence, athletes previously experiencing exercise-related 
functional impairment orevidence of myocardial ischemia due 
to heart disease are less likely to have appeared in our 
population. For these reasons, we probably can not assume 
that the frequency with which sudden death occurs (or heart 
disease is present) in a large cohort of marathon runners is 
necessarily the same as in other strenuous sports. 
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Figure 1. Participation in the marathon race over a 19- 
year period in both Washington, D.C. and Minneapolis-St. 
Paul, Minnesota. The years of occurrence of sudden death 
are shown as open bars. 
 ,5o 1 
125- 
"~ lOO- 
75- 
50- 
d 
~" 25-  
'76 77 '78 '79 '80 '81 '82 '83 '84 '85 '86 
i i ~ J i i 
'87 '88 '89 '90 '91 '92 '93 '94 
Conclusions. There has been substantial interest in the 
potential value and feasibility of preparticipation screening for 
cardiovascular disease in large populations of trained athletes 
(31,32). Although the present study does not offer definitive 
resolution of such screening issues, the particularly low prev- 
alence of sudden death that we identified over a 30-year period 
suggests that the routine screening of such an athletic popula- 
tion may not be entirely justified in terms of the cost and 
resources required. 
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